Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 5
Submit an article Journal homepage
2,421
Views
35
CrossRef citations to date
0
Altmetric
Original Research

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells

V. LeuciDepartment of Oncology, University of Torino, Torino, Italy;Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyView further author information
,
M. CasucciInnovative Immunotherapies Unit, IRCCS San Raffaele Hospital Scientific Institute, Milano, ItalyView further author information
,
G. GrignaniDivision of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyView further author information
,
R. RotoloDepartment of Oncology, University of Torino, Torino, ItalyView further author information
,
U. RossottiDepartment of Oncology, University of Torino, Torino, ItalyView further author information
,
E. VignaDepartment of Oncology, University of Torino, Torino, Italy;Laboratory of Gene Transfer, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, ItalyORCID Iconhttp://orcid.org/0000-0001-9787-5732View further author information
ORCID Icon,
L. GammaitoniDivision of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyView further author information
,
G. MesianoDivision of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyView further author information
,
E. FiorinoDepartment of Oncology, University of Torino, Torino, ItalyView further author information
,
C. DoniniDepartment of Oncology, University of Torino, Torino, ItalyView further author information
,
A. PisacanePathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, (TO), ItalyView further author information
,
L. D. ambrosioDepartment of Oncology, University of Torino, Torino, Italy;Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyORCID Iconhttp://orcid.org/0000-0003-3294-8819View further author information
ORCID Icon,
Y. PignochinoDepartment of Oncology, University of Torino, Torino, Italy;Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyView further author information
,
M. AgliettaDepartment of Oncology, University of Torino, Torino, Italy;Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyView further author information
,
A. BondanzaInnovative Immunotherapies Unit, IRCCS San Raffaele Hospital Scientific Institute, Milano, Italy;Vita-Salute San Raffaele University, Milano, ItalyView further author information
&
D. SangioloDepartment of Oncology, University of Torino, Torino, Italy;Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7163-7071View further author information
ORCID Icon show all
Article: e1423167 | Received 01 Sep 2017, Accepted 22 Dec 2017, Published online: 15 Feb 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.